Pages that link to "Q39596882"
Jump to navigation
Jump to search
The following pages link to Teratogen update: valproic acid (Q39596882):
Displaying 50 items.
- Craniorachischisis totalis (Q22336964) (← links)
- Maternal periconceptional occupational pesticide exposure and neural tube defects (Q23914646) (← links)
- Valproic acid teratogenicity: a toxicogenomics approach (Q24813390) (← links)
- Epilepsy during pregnancy: focus on management strategies (Q28080299) (← links)
- Valproate and spina bifida (Q28340864) (← links)
- Ribonucleotide reductase subunit R1: a gene conferring sensitivity to valproic acid-induced neural tube defects in mice (Q28373189) (← links)
- A structured approach to brain injury rehabilitation (Q28743263) (← links)
- A method for human teratogen detection by geometrically confined cell differentiation and migration (Q30650021) (← links)
- The Use of Folic Acid for the Prevention of Neural Tube Defects and Other Congenital Anomalies (Q33357503) (← links)
- Neural tube defects--disorders of neurulation and related embryonic processes (Q33620903) (← links)
- Neural tube defects: recent advances, unsolved questions, and controversies (Q33620909) (← links)
- Update on new developments in the study of human teratogens. (Q34123327) (← links)
- Permeation across hydrated DPPC lipid bilayers: simulation of the titrable amphiphilic drug valproic acid (Q34183816) (← links)
- The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation (Q34349772) (← links)
- Drug-induced congenital defects: strategies to reduce the incidence (Q34458527) (← links)
- Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies (Q34492216) (← links)
- Major malformations with valproic acid. (Q34517882) (← links)
- Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists (Q34707032) (← links)
- Looking for causes of neural tube defects: where does the environment fit in? (Q34832860) (← links)
- The epidemiology of disasters and adverse reproductive outcomes: lessons learned (Q34847956) (← links)
- Review of neural tube defects: risk factors in parental occupation and the environment (Q35031927) (← links)
- Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in mice (Q35045414) (← links)
- Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established (Q35127991) (← links)
- Valproate (Q35142736) (← links)
- Brief report novel mechanism for valproate-induced teratogenicity. (Q35414137) (← links)
- Gender differences in bipolar disorder (Q35561522) (← links)
- Periconceptional maternal alcohol consumption and neural tube defects (Q35618730) (← links)
- Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity. Aspects of species variation, pharmacokinetics, metabolism and implications of structural specificity for the development of alternative antiepilepti (Q35690870) (← links)
- Clinical utility of folate-containing oral contraceptives (Q35940242) (← links)
- Working towards a risk prediction model for neural tube defects (Q36057792) (← links)
- Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice (Q36244649) (← links)
- A standardized human embryoid body platform for the detection and analysis of teratogens (Q36275388) (← links)
- Genetic variation in genes of folate metabolism and neural-tube defect risk (Q36467477) (← links)
- Use of antiepileptic medications in pregnancy in relation to risks of birth defects (Q36751405) (← links)
- The continuing challenge of understanding, preventing, and treating neural tube defects. (Q36914843) (← links)
- Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency (Q36952666) (← links)
- Acephalous lamb from an in vitro-produced sheep embryo (Q37165888) (← links)
- Intersection of complex genetic traits affecting maternal metabolism, fetal metabolism, and neural tube defect risk: looking for needles in multiple haystacks (Q37695522) (← links)
- Epilepsy and pregnancy--a review of 98 pregnancies (Q37786706) (← links)
- Therapeutic drug monitoring in pregnancy: rationale and current status (Q38037879) (← links)
- Genetic studies of myelomeningocele (Q38135224) (← links)
- Cloning and Characterization of ChickenParaxis:A Regulator of Paraxial Mesoderm Development and Somite Formation (Q38343239) (← links)
- Valproic acid-induced somite teratogenesis in the chick embryo: relationship with Pax-1 gene expression (Q38354437) (← links)
- Potential human developmental toxicants and the role of animal testing in their identification and characterization (Q38625359) (← links)
- Deleterious effects of drugs on the developing nervous system. (Q38657897) (← links)
- Prenatal exposure to environmental factors and congenital limb defects (Q38987429) (← links)
- Interaction between the SLC19A1 gene and maternal first trimester fever on offspring neural tube defects (Q40204079) (← links)
- Associations between post translational histone modifications, myelomeningocele risk, environmental arsenic exposure, and folate deficiency among participants in a case control study in Bangladesh (Q40253479) (← links)
- Inducible 70 kDa heat shock proteins protect embryos from teratogen-induced exencephaly: Analysis using Hspa1a/a1b knockout mice (Q40383650) (← links)
- Course of psychiatric disorders in pregnancy. Dilemmas in pharmacologic management. (Q40649469) (← links)